{"entity":{"type":"insider","cik":"0001864112","url":"/insider/0001864112","json_url":"/insider/0001864112.json","name":"Kathiresan Sekar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":8,"first":"2021-06-21","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Kathiresan Sekar","source":"filing","n_filings":8,"first_seen":"2021-06-21","last_seen":"2025-04-03"}],"transactions":[{"id":4749953,"accession":"0000950170-25-050563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-050563","line_url":"/filing/0000950170-25-050563#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9822.0,"shares_display":"9,822","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":40761.3,"total_display":"40,761.30","total_whole":"40,761","shares_owned_after":346686.0,"shares_owned_after_display":"346,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-03","scope":"insider"},{"id":6574546,"accession":"0001209191-22-052799","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-052799","line_url":"/filing/0001209191-22-052799","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":33.652442758,"price_display":"33.65","price_state":"stated","total_value":1682622.1379,"total_display":"1,682,622.14","total_whole":"1,682,622","shares_owned_after":338928.0,"shares_owned_after_display":"338,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider","n_lines":3},{"id":6305362,"accession":"0001209191-22-045447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-045447","line_url":"/filing/0001209191-22-045447#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":29.9,"price_display":"29.90","price_state":"stated","total_value":1495000.0,"total_display":"1,495,000.00","total_whole":"1,495,000","shares_owned_after":317839.0,"shares_owned_after_display":"317,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6892850,"accession":"0001209191-22-042871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042871","line_url":"/filing/0001209191-22-042871#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":29.9,"price_display":"29.90","price_state":"stated","total_value":1495000.0,"total_display":"1,495,000.00","total_whole":"1,495,000","shares_owned_after":317839.0,"shares_owned_after_display":"317,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-21","scope":"insider"},{"id":6471073,"accession":"0000899243-22-001203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-001203","line_url":"/filing/0000899243-22-001203#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1870.0,"shares_display":"1,870","price_per_share":39.9,"price_display":"39.90","price_state":"stated","total_value":74613.0,"total_display":"74,613.00","total_whole":"74,613","shares_owned_after":406536.0,"shares_owned_after_display":"406,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":4827450,"accession":"0000899243-21-050032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-050032","line_url":"/filing/0000899243-21-050032#line-6","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6693.0,"shares_display":"6,693","price_per_share":39.9,"price_display":"39.90","price_state":"stated","total_value":267050.7,"total_display":"267,050.70","total_whole":"267,051","shares_owned_after":406536.0,"shares_owned_after_display":"406,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-29","scope":"insider"},{"id":4827442,"accession":"0000899243-21-050032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-050032","line_url":"/filing/0000899243-21-050032","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":40.20199481190476,"price_display":"40.20","price_state":"stated","total_value":1688483.7821,"total_display":"1,688,483.78","total_whole":"1,688,484","shares_owned_after":412093.0,"shares_owned_after_display":"412,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-29","scope":"insider","n_lines":3},{"id":4930470,"accession":"0000899243-21-049812","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-049812","line_url":"/filing/0000899243-21-049812#line-7","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57000.0,"shares_display":"57,000","price_per_share":39.9,"price_display":"39.90","price_state":"stated","total_value":2274300.0,"total_display":"2,274,300.00","total_whole":"2,274,300","shares_owned_after":406536.0,"shares_owned_after_display":"406,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-27","scope":"insider"},{"id":4930465,"accession":"0000899243-21-049812","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-049812","line_url":"/filing/0000899243-21-049812","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57000.0,"shares_display":"57,000","price_per_share":38.707084724561405,"price_display":"38.71","price_state":"stated","total_value":2206303.8293,"total_display":"2,206,303.83","total_whole":"2,206,304","shares_owned_after":409805.0,"shares_owned_after_display":"409,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-27","scope":"insider","n_lines":4},{"id":4162951,"accession":"0000899243-21-025070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025070","line_url":"/filing/0000899243-21-025070#line-1","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864112","owner_name":"Kathiresan Sekar","owner_display_name":"Kathiresan Sekar","owner_url":"/insider/0001864112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":47500.0,"total_display":"47,500.00","total_whole":"47,500","shares_owned_after":406536.0,"shares_owned_after_display":"406,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Director, Officer (Chief Executive Officer)","n_filings":8,"first_seen":"2021-06-21","last_seen":"2025-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001864112","retrieved_at":"2026-08-23T04:44:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}